Accreditation, Publication Information, and Post-Test

Scroll down for a link to the post-test.

Learning Objectives

After reading this Clinical Proceedings, individuals will be able to:

• Define interstitial cystitis/painful bladder syndrome (IC/PBS).
• Identify the characteristic signs and symptoms of IC/PBS.
• List six tools used in the basic diagnostic assessment of IC/PBS.
• Identify the three basic components of IC/PBS management.
• Identify four elements to consider when counseling individuals with IC/PBS.

Supporter Acknowledgement

Funding for this publication was provided by an educational grant from Ortho Women’s Health and Urology.

Clinical Advisors

Philip Hanno, MD
Mary W. L. Lee, PharmD, BCPS, FCCP
Robert Moldwin, MD
Diane K. Newman, RNC, MSN, CRNP, FAAN

This publication is part of a joint ARHP/ICA program that also included the following clinical advisors: David Burks, MD, Michael Chancellor, MD, Robert Evans, MD, Fred Howard, MD, Kenneth Peters, MD, Lee P. Shulman, MD, Diane A. Smith, MSN, CRNP, and Kristene Whitmore, MD.

Contributing Staff and Consultants

Shama Alam, MScPH, ARHP Education Associate
Jenn Baldwin, Consulting Designer
Ann Chesnut, ICA Director of Communications
Beth Jordan, MD, ARHP Medical Director
Allison Tombros Korman, MHS, ARHP Associate Director of Education
Libby Mullin, ICA Government Affairs Consultant
Lucretia Perilli, ICA Director of Medical Communications
Diane Shannon, MD, MPH, Consulting Writer
Wayne C. Shields, ARHP President and CEO
Amy M. Swann, MA, ARHP Director of Education

Financial Disclosure Information

The following committee members and/or contributing staff have a financial interest or affiliation with the manufacturers of commercial products possibly related to topics covered in this issue of Clinical Proceedings. These financial interests or affiliations are in the form of grants, research support, speaker support, or other support. This support is noted to fully inform readers and should not have an adverse impact on the information provided within this publication.

Chancellor: Receives grants/research support from Astellas Pharma, Inc., Pfizer Inc., Cook Group Incorporated, and Allergan, Inc.; Consultant for Astellas Pharma, Inc., Pfizer Inc., Cook Group Incorporated, and Allergan, Inc.

Evans: Receives grants/research support from Ortho Women’s Health and Urology, Astellas Pharma, Inc., Medtronic, Inc., Cook Group Incorporated, Indevus Pharmaceuticals, ANS Medical; Speaker for Ortho Women’s Health and Urology, Astellas Pharma, Inc., and Indevus Pharmaceuticals.

Hanno: Consultant for Astellas Pharma, Inc., and Watson Pharmaceuticals.

Howard: Consultant for Ethicon Women’s Health and Urology, and Ortho Women’s Health and Urology.

Moldwin: Receives grants/research support from Plethora Solutions; Consultant for Ortho-McNeil Pharmaceuticals and Allergan, Inc.; Speaker for Ortho-McNeil Pharmaceuticals.

Peters: Consultant for Medtronic, Inc.

Shulman: Receives grants/research support from Barr-Duramed and Lilly/Boehringer Ingelheim; Consultant for Barr-Duramed, Ortho-McNeil Pharmaceuticals, Bayer HealthCare Pharmaceuticals, and Organon; Speaker for Barr-Duramed, Ortho-McNeil Pharmaceuticals, Wyeth Pharmaceuticals, Bayer HealthCare Pharmaceuticals, Organon, Merck & Co, Inc., and GlaxoSmithKline.

Smith: Consultant for Colpexin Sphere; Speaker for Watson Pharmaceuticals and Novartis.

Whitmore: Receives research support from Advanced Bionics, Medtronic, Inc., Ortho-McNeil Pharmaceuticals, Pfizer Inc., and Yamanouchi Pharmaceutical Co.; Advisor for Boston-Scientific, Lilly/Boehringer Ingelheim, Medtronic, Inc., and Ortho-McNeil Pharmaceuticals; Speaker for Lilly/Boehringer Ingelheim, Ortho-McNeil, Pfizer Inc., and Yamanouchi Pharmaceutical Co.

Alam, Baldwin, Burks, Chestnut, Jordan, Korman, Lee, Mullin, Newman, Perilli, Shannon, Shields, and Swann have no affiliations to disclose.

Accreditation/Credit Designation

Participants who correctly answer at least 70% of the post-test questions will receive continuing education credit. If you have any questions, please contact ARHP staff at (202) 466-3825 or arhp@arhp.org. You will receive a certificate of completion within four weeks of submitting the post-test.

Physicians—ARHP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education (CME) for physicians. ARHP designates this continuing medical education activity for 2 credit hours in Category 1 of the Physician’s Recognition Award of the American Medical Association.

Nurses and Nurse Practitioners—This educational activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health for 2 contact hours, including 1.2 pharmacology hours. Credit can be applied toward the nursing continuing education requirements of most professional organizations and state Boards of Nursing.

Nurse Midwives—ACCME credit hours in Category 1 are accepted by the Continuing Competency Assessment Program of the American College of Nurse Midwives for programs relevant to nurse midwifery. Nurse Midwives who complete this activity may report up to 2 hours of credit.

Physician Assistants—The American Academy of Physician Assistants accepts Category 1 CME approval from organizations accredited by the ACCME. Physician Assistants who complete this activity may report up to 2 hours of credit.

Pharmacists—ARHP is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The assigned universal program number is 463-000-08-007-H04-P. This activity provides 2 contact hours of continuing education credit.

Technical Requirements

Direct internet connection with standard browser is needed. A broadband connection is recommended.

Post-Test

To take the post-test, click the link below to be taken to a login page where you can set up an account or login (if you haven't already created an account at ARHP.org).  If you have any questions regarding your account, please e-mail education@arhp.org or call (202) 466-3825.

Please click here to view the post-test.